DIALYSIS · Loading…
DIALYSIS · CCN 492695
DaVita Nansemond Dialysis
SUFFOLK, VA 23434
DialysisProfitDaVita
$4.4M
TOTAL REVENUE
34.0%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL
Cost report financials (FY2024)
- Net patient revenue
- $4.4M
- Total costs
- $2.9M
- Operating income (rev − costs)
- $1.5M
- Operating margin
- 34.0%
- Total charges
- $4.5M
- Total treatments
- 11,669
- Dialysis stations
- 13
Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.
02 — QUALITY MEASURES
13 quality measures
| Measure | Score | Denominator | Period |
|---|---|---|---|
Standardized ED Visits Within 30 Days of Hospital Discharge DFC_ED30 | 1.77 | 26 | — |
Fistula Rate DFC_FISTULA_RATE | 55.4 | 66 | — |
Five Star Rating DFC_FIVE_STAR | 4 | — | — |
First Year Standardized Kidney Transplant Waitlist Ratio DFC_FYSWR | 3.94 | 43 | — |
Healthcare Worker COVID-19 Vaccination Adherence DFC_HCP_VACC | 4 | — | — |
Patient Hospitalization Rate DFC_HOSPITALIZATION_RATE | 118.4 | 74 | — |
Standard Infection Ratio (SIR) DFC_INFECTION_RATIO | 0 | — | — |
Percentage of Adult Patients with Long Term Catheter in Use DFC_LONG_CATHETER | 23 | 66 | — |
Patient Survival (Mortality Rate) DFC_MORTALITY_RATE | 22.6 | 279 | — |
Percentage of Prevalent Patients Waitlisted for Kidney Transplant DFC_PPPW | 26.3 | 75 | — |
Patient Hospital Readmission Rate DFC_READMISSION_RATE | 22.9 | 69 | — |
Standardized ED Visits Ratio DFC_SEDR | 0.89 | 28 | — |
Patient Transfusion Rate DFC_TRANSFUSION_RATE | 0 | 24 | — |